Covered recipient · General Payments record
JULIE HUANG
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2020–2024
$7,354.27
- Reported across 288 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,719.58 | 52 |
| Education | $184.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $252.57 | 7 |
| Acerta Pharma LLC | $212.91 | 6 |
| Janssen Biotech, Inc. | $177.65 | 6 |
| Astellas Pharma US Inc | $140.70 | 2 |
| Exelixis Inc. | $135.00 | 1 |
| Merck Sharp & Dohme Corporation | $125.00 | 1 |
| Incyte Corporation | $99.99 | 1 |
| PFIZER INC. | $99.92 | 2 |
| Genmab U.S., Inc. | $90.85 | 3 |
| Sumitomo Pharma America, Inc. | $80.39 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $73.39 | 3 |
| Agios Pharmaceuticals, Inc. | $47.65 | 2 |
| E.R. Squibb & Sons, L.L.C. | $43.10 | 2 |
| Mirati Therapeutics, Inc. | $36.66 | 2 |
| Lilly USA, LLC | $31.24 | 1 |
| Karyopharm Therapeutics Inc. | $29.94 | 1 |
| Deciphera Pharmaceuticals Inc. | $28.82 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $22.12 | 1 |
| Kyowa Kirin, Inc. | $21.99 | 1 |
| EISAI INC. | $21.21 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.88 | 1 |
| TAIHO ONCOLOGY, INC. | $20.88 | 1 |
| TACTILE SYSTEMS TECHNOLOGY INC | $20.43 | 1 |
| Pharmacosmos Therapeutics Inc. | $19.95 | 1 |
| GENZYME CORPORATION | $17.57 | 1 |
| Apellis Pharmaceuticals, Inc. | $17.57 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.